Abstract
The application of in vitro and in vivo ATP bioluminescence systems as an integrated approach for preclinical research and development of new chemotherapeutic drugs is described. This approach includes both (a) the in vitro tumor response assay (TRA) system that utilizes new technologies for cell culture and ATP measurement of clinical specimens and (b) the use of human tumor cell lines transfected with Photinus pyralis luciferase (luc) gene for both in vitro and in vivo studies. Dried reagent microplates for TRA culture and counting procedures are described for a two-stage TRA method, which can be used to evaluate drug sensitivity and resistance of cells from clinical specimens after initial drug exposure in vitro. The use of dried reagent counting plates for screening and testing of agents against tumor cell lines is described, as well as an alternative method for screening and testing chemotherapeutic drugs in vitro with luc-transfected human tumor cell lines. The potential application of luc-transfected reporter cell lines for in vivo studies of drug activity with photon imaging for analysis is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maehara Y, Miyamoto K, Anai H, et al (1987) The ATP assay is more sensitive than succinate dehydrogenase inhibition test for predicting cell viability. Eur J Cancer Clin Oncol 23:273
Kangas L, Gronroos M, Nieminem AL (1984) Bioluminescence of cellular ATP: A new method for evaluating cytotoxic agents in vitro. Med Biol 62:338
Sevin B, Peng Z, Perras J, Penalver G, Averette H (1988) Application of ATP bioluminescence assay in human tumor chemosensitivity testing. Gynecol. Oncol 31:191–204
Sevin B, Perras JP, Averette H, Donato D, Penalver M (1993) Chemosensitivity testing in ovarian cancer. Cancer 71:1613–1620
Andreotti P, Cree I, Kurbacher C, Hartmann D, Linder D, Harel G, Gleiberman I, Caruso P, Ricks S, Untch M, Sartori C, Bruckner H (1995) Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Research 55:5276–5282
Hunter EM, Sutherland LA, Cree IA, Dewar JA, Preece PE, Wood RA, Linder D, Andreotti PE (1993) Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay. Eur J Surg Oncol. 19:242–249
Cree IA, Kurbacher CM (1999) ATP-based tumor chemosensitivity testing: assisting new agent development. Anti-Cancer Drugs 10:431–435
Cree IA, Kurbacher CM, Untch M, Sutherland LA, Hunter EM, Subedi AMC, James EA, Dewar JA, Preece PE, Andreotti PE, Bruckner HW (1996) Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity. Anti-Cancer Drugs 7:630–635
Kurbacher C, Bruckner HW, Cree IA, Andreotti P, Janut MM (1999) A prospective clinical trial on individualized chemotherapy for recurrent ovarian cancer selected by the ex vivo ATP tumor chemosensitivity assay. American Society of Clinical Oncology 1384
Kurbacher C, Cree IA, Bruckner H, Brenne U, Kurbacher J, Muller K, Ackermann T, Gilster T, Wilhelm L, Engel H, Mallmann P, Andreotti P (1998) Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anti-Cancer Drugs 9:51–57
Kurbacher CM, Cree IA, Bruckner HW, Mallmann P, Andreotti PE (1998) Chemotherapy directed by the ATP tumour chemosensitivity assay improves response rates and survival for patients with recurrent ovarian cancer. Anti-Cancer Drugs 9:51–57
Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CS (1999) Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1:303–310
Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CS, Ross BD (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491–495
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Andreotti, P.E., Caceres, G., Zamkina, R., Dauphinée, M. (2003). Luminescence Applications for Chemotherapeutic Drug Development. In: Reinhold, U., Tilgen, W. (eds) Chemosensitivity Testing in Oncology. Recent Results in Cancer Research, vol 161. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19022-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-19022-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62412-4
Online ISBN: 978-3-642-19022-3
eBook Packages: Springer Book Archive